Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Balant

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Therapeutic Drug Monitoring|February 1, 1995
Potential of concentration monitoring data for a short half-life drug: analysis of pharmacokinetic variability for moclobemideM Gex-Fabry, A E Balant-Gorgia, L P Balant
Clinical Pharmacokinetics|June 1, 1991
Clinical pharmacokinetics of clomipramineA E Balant-Gorgia, M Gex-Fabry, L P Balant
British Journal of Clinical Pharmacology|July 1, 1985
Slow release choline theophyllinate (Sabidal SR 270) in chronic asthmaS J Berg, L P Balant, I Clarke, et al.
Therapeutic Drug Monitoring|January 1, 1985
Comparative determination of flupentixol in plasma by gas chromatography and radioimmunoassay in schizophrenic patientsA E Balant-Gorgia, L P Balant, C Genet, et al.
Therapeutic Drug Monitoring|April 1, 1992
Persistent impairment of clomipramine demethylation in recently detoxified alcoholic patientsA E Balant-Gorgia, M Gay, M Gex-Fabry, et al.
Clinical Pharmacokinetics|September 1, 1990
Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring dataM Gex-Fabry, A E Balant-Gorgia, L P Balant, et al.
Therapeutic Drug Monitoring|March 2, 1999
Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factorsA E Balant-Gorgia, M Gex-Fabry, C Genet, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1987
Stereoselective disposition of flupentixol: influence on steady-state plasma concentrations in schizophrenic patientsA E Balant-Gorgia, L P Balant, M Gex-Fabry, et al.
Clinical Therapeutics|January 1, 1985
Treatment of major depressive disorder with melancholiaA E Balant-Gorgia, L P Balant, N Aapro, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Relevance of genetic polymorphism in drug metabolism in the development of new drugsL P Balant, U Gundert-Remy, A R Boobis, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Therapeutic Drug Monitoring|February 1, 1995
Potential of concentration monitoring data for a short half-life drug: analysis of pharmacokinetic variability for moclobemideM Gex-Fabry, A E Balant-Gorgia, L P Balant
Clinical Pharmacokinetics|June 1, 1991
Clinical pharmacokinetics of clomipramineA E Balant-Gorgia, M Gex-Fabry, L P Balant
British Journal of Clinical Pharmacology|July 1, 1985
Slow release choline theophyllinate (Sabidal SR 270) in chronic asthmaS J Berg, L P Balant, I Clarke, et al.
Therapeutic Drug Monitoring|January 1, 1985
Comparative determination of flupentixol in plasma by gas chromatography and radioimmunoassay in schizophrenic patientsA E Balant-Gorgia, L P Balant, C Genet, et al.
Therapeutic Drug Monitoring|April 1, 1992
Persistent impairment of clomipramine demethylation in recently detoxified alcoholic patientsA E Balant-Gorgia, M Gay, M Gex-Fabry, et al.
Clinical Pharmacokinetics|September 1, 1990
Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring dataM Gex-Fabry, A E Balant-Gorgia, L P Balant, et al.
Therapeutic Drug Monitoring|March 2, 1999
Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factorsA E Balant-Gorgia, M Gex-Fabry, C Genet, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1987
Stereoselective disposition of flupentixol: influence on steady-state plasma concentrations in schizophrenic patientsA E Balant-Gorgia, L P Balant, M Gex-Fabry, et al.
Clinical Therapeutics|January 1, 1985
Treatment of major depressive disorder with melancholiaA E Balant-Gorgia, L P Balant, N Aapro, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Relevance of genetic polymorphism in drug metabolism in the development of new drugsL P Balant, U Gundert-Remy, A R Boobis, et al.
Pageof 7